Published: 2021-02-03 13:51 | Updated: 2021-02-17 14:51

Interviews with experts in the NK cell and engager drug development field

In the Innate Killer Magazine 2021 Hans-Gustaf Ljunggren, together with other experts in the NK cell and engager drug development field, shares his thoughts on the future of combination therapy. He also describes the NK cell research going on at KI and what challenges he can identify in the field of NK cell therapy.

Link to the magazine